Limited evidence for the health effects and safety of intermittent fasting among patients with type 2 diabetes
Mechanistic studies in animal models suggest that mucosal targeting is likely to offer better protection against respiratory infections [43], but methods for inducing mucosal immunity are in the earliest stages of testing
Published on December 10th, 2025
Injecting the solvent slowly down the side of the vial, rather than directly onto the powder, prevents a forceful impact that can damage the peptide structure
8-hydroxy-2-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease
We see a lot of misconceptions about how to use AHK-Cu peptide, so we put together this quick guide to walk you through the protocol